Gujarat Terce Laboratories Limited (BOM:524314)
33.96
-0.54 (-1.57%)
At close: Jun 17, 2026
BOM:524314 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 28.6 | 7.79 | 0.9 | 20.3 | 15.09 |
Short-Term Investments | 13.48 | 5.11 | - | - | - |
Cash & Short-Term Investments | 42.08 | 12.91 | 0.9 | 20.3 | 15.09 |
Cash Growth | 225.97% | 1334.22% | -95.57% | 34.50% | 17.32% |
Accounts Receivable | 48.67 | 50.69 | 56.63 | 79.86 | 54.75 |
Other Receivables | - | 0.48 | 0.43 | 1.36 | 6.01 |
Receivables | 50.4 | 52.9 | 58.75 | 82.51 | 62.04 |
Inventory | 37.26 | 36.78 | 39.29 | 44.3 | 64.31 |
Prepaid Expenses | - | 1.83 | 1.68 | 2.8 | 2.23 |
Other Current Assets | 14.35 | 15.83 | 11.61 | 10.58 | 11.07 |
Total Current Assets | 144.08 | 120.25 | 112.22 | 160.48 | 154.75 |
Property, Plant & Equipment | 32.49 | 36.54 | 36.92 | 39.88 | 42.93 |
Long-Term Investments | 0.04 | 0.04 | 2.73 | 2.72 | 2.72 |
Long-Term Deferred Tax Assets | 7.03 | 4.34 | 12.22 | 15.23 | 3 |
Other Long-Term Assets | 44.76 | 45.56 | 47.41 | 46.49 | 46.44 |
Total Assets | 245.51 | 228.28 | 232.74 | 285.27 | 273.91 |
Accounts Payable | 15.8 | 36.14 | 47.13 | 58.51 | 40.25 |
Accrued Expenses | - | 79.52 | 39.34 | 45.05 | 44.2 |
Short-Term Debt | - | 0.14 | 22.04 | 49.81 | 37.74 |
Current Portion of Long-Term Debt | 12.66 | 6.3 | 7.36 | 8.3 | 5.97 |
Current Income Taxes Payable | 0.81 | - | - | - | - |
Other Current Liabilities | 80.19 | 4.33 | 5.55 | 4.41 | 3.97 |
Total Current Liabilities | 109.46 | 126.43 | 121.42 | 166.08 | 132.14 |
Long-Term Debt | 0.3 | 2.98 | 9.27 | 14.61 | 23 |
Long-Term Unearned Revenue | 14.92 | 18.92 | 13.77 | 18.97 | 19.27 |
Pension & Post-Retirement Benefits | 23.55 | 15.17 | 17.21 | 16.98 | 14.15 |
Other Long-Term Liabilities | - | - | 0 | - | - |
Total Liabilities | 148.23 | 163.5 | 161.68 | 216.64 | 188.56 |
Common Stock | 77.91 | 74.2 | 74.2 | 74.2 | 74.2 |
Additional Paid-In Capital | - | 15 | 15 | 15 | 15 |
Retained Earnings | - | -27.93 | -18.14 | -20.58 | -3.86 |
Comprehensive Income & Other | 19.37 | 3.5 | - | - | - |
Shareholders' Equity | 97.28 | 64.78 | 71.06 | 68.63 | 85.34 |
Total Liabilities & Equity | 245.51 | 228.28 | 232.74 | 285.27 | 273.91 |
Total Debt | 12.96 | 9.42 | 38.67 | 72.72 | 66.72 |
Net Cash (Debt) | 29.11 | 3.49 | -37.77 | -52.42 | -51.63 |
Net Cash Growth | 734.18% | - | - | - | - |
Net Cash Per Share | 3.86 | 0.47 | -5.09 | -7.06 | -6.96 |
Filing Date Shares Outstanding | 7.77 | 7.42 | 7.42 | 7.42 | 7.42 |
Total Common Shares Outstanding | 7.77 | 7.42 | 7.42 | 7.42 | 7.42 |
Working Capital | 34.63 | -6.18 | -9.2 | -5.6 | 22.61 |
Book Value Per Share | 12.52 | 8.73 | 9.58 | 9.25 | 11.50 |
Tangible Book Value | 97.28 | 64.78 | 71.06 | 68.63 | 85.34 |
Tangible Book Value Per Share | 12.52 | 8.73 | 9.58 | 9.25 | 11.50 |
Land | - | 0.31 | 0.31 | 0.31 | 0.31 |
Buildings | - | 22.38 | 22.38 | 22.38 | 22.38 |
Machinery | - | 64.82 | 61.35 | 60.65 | 60.1 |